Kim Lorence H. 4
4 · Revolution Medicines, Inc. · Filed Jul 25, 2022
Insider Transaction Report
Form 4
Kim Lorence H.
Director
Transactions
- Purchase
Common Stock
2022-07-22$20.00/sh+50,000$1,000,000→ 60,500 total
Footnotes (1)
- [F1]Includes 10,500 Restricted Stock Units.